# Risk: __Risk of resistance development to anti-SARS-CoV-2 coatings__ (PBN__Risk_1181)

## Property: has_RiskSubject

* [general population](../Stakeholder/PBN__Stakeholder_9)
* [healthcare workers](../Stakeholder/PBN__Stakeholder_68)

## Property: has_RiskISO_Impact

* [Biodiversity and ecosystem services](../RiskISO/PBN__RiskISO_Purpose_4)

## Property: has_RiskSource

* [behzadinasab_surface_2020](../Article/PBN__Article_199)

## Property: has_RiskName

Reduced effectiveness of anti-SARS-CoV-2 coatings and increased transmission

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

## Property: has_RiskGBN

* [Yes](../RiskGBN/PBN__RiskGBN_1)

## Property: has_RiskTechnology

* [surveillance programs](../Technology/PBN__Technology_268)
* [research and development](../Technology/PBN__Technology_269)

## Property: has_RiskOwner

* [researchers](../Stakeholder/PBN__Stakeholder_2)
* [manufacturers](../Stakeholder/PBN__Stakeholder_34)
* [public health authorities](../Stakeholder/PBN__Stakeholder_0)

## Property: has_RiskType

* [technological](../RiskType/PBN__RiskType_5)

## Property: has_RiskDescription

Continued use of the same coatings may lead to the development of resistance in the virus

## Property: has_RiskISO_Purpose

* [Responsible resource use](../RiskISO/PBN__RiskISO_Impact_4)

## Property: has_RiskMitigation

* [Regular monitoring of coated surfaces for changes in viral viability and development of alternative coatings](../RiskMitigation/PBN__RiskMitigation_1633)

